珠海润都制药股份有限公司关于布洛芬片获得药品注册证书的公告

Group 1 - The company has received a drug registration certificate for Ibuprofen Tablets from the National Medical Products Administration, indicating compliance with relevant drug registration requirements [1][3] - The drug is classified as a Class 3 chemical drug and is approved for over-the-counter management, which may enhance its marketability [1][2] - The approval of Ibuprofen Tablets expands the company's analgesic and antipyretic product line, potentially benefiting more patients and positively impacting the company's operational performance [3] Group 2 - The drug is indicated for the relief of mild to moderate pain, including headaches, joint pain, migraines, toothaches, muscle pain, neuralgia, and dysmenorrhea, as well as fever caused by common colds or influenza [2] - The company emphasizes strict control over the quality and safety of drug research, manufacturing, and sales processes [3]